Our study showed that patients with HFrEF and HFpEF who did not receive SGLT2i, as part of their HF treatment, had increased fibrinogen levels between T1 and T0, while the CRP and ESR remained the same between the two visits. This evidence concerns the gene CRP and hydrops fetalis.